McGusto, I figured as much. Be patient & you will be rewarded. Investors won't ignore how undervalued MDT is forever, just give it time.Not an exciting day, but interesting nonetheless.Is anyone else buying today??Cheers.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress